{
    "nctId": "NCT05189717",
    "briefTitle": "A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of Adults",
    "officialTitle": "A Single-arm, Open-label and Multi-center Phase I Study on Safety, Tolerance and Pharmacokinetics of HRS-8080 Tablets Monotherapy and Combined With Other Anti-cancer Therapy in Patients With Metastatic or Local Advanced Breast Cancer",
    "overallStatus": "ENROLLING_BY_INVITATION",
    "conditions": "Metastatic or Local Advanced Breast Cancer of Patients",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 156,
    "primaryOutcomeMeasure": "Maximum tolerated dose",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. ECOG performance status score: 0-1;\n2. Histopathologically documented local advanced or metastatic breast cancer ;\n3. Female of not childbearing potential must the related requirement;\n4. During or after the last systematic therapy before enrolment, disease progression occurred with clinical or radiographical documentation;\n5. Adequate organ functions as defined;\n6. Ability to understand and voluntarily agrees to participate by giving written informed consent for the study.\n\nExclusion Criteria:\n\n1. For the case of symptomatic visceral metastasis, the investigators judged that it was not suitable to use relevant treatment;\n2. patients with active brain metastasis (without medical control or with clinical symptoms), cancerous meningitis, spinal cord compression, or patients with a history of primary tumors of the central nervous system ;\n3. History of clinically significant cardiovascular or cerebrovascular diseases;\n4. The subject has one of many factors affecting oral drugs;\n5. Active infection or fever with unknown cause \\> 38.5 \u00b0C;\n6. Active autoimmune diseases, History of immunodeficiency, including positive HIV serum test result and other acquired or congenital immunodeficiency diseases, or history of organ transplantation;\n7. Known history of allergy to study drug ingredients.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}